1. Balfour DJK and Fagerstrom KO (1996) Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Ther 72: 51-81
2. McGehee DS and Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57: 521-546
3. Picciotto MR (1998) Common aspects of the action of nicotine and other drugs of abuse. Drug Alcohol Depend 51: 165-172
4. Ferry LH.. Non-nicotine pharmacotherapy for smoking cessation. Prim Care. 1999 Sep;26(3):653-69.
5. Kuhar MJ, Central Cholinergic pathways: physiologic and pharmacologic aspects. Psychopharamacology A Generation of Progress, Raven Press, NY 1978, pp199-204.
6. Kerlavage, AR, et al, Muscarinic cholinergic receptor structure: molecular biological support for subtypes. Trends Pharmacol. Sci., 1987, 8, 426-429.
7. Gillman AG, Rall TW, Taylor P, and Nies AS, Goodman and Gillman’s The Pharmacologic Basis of Therapeutics, 8th edition, Macmillan Pub, 1990.
8. Ketchum JS, Sidell FR, Crowell EB Jr. Atropine, scopolamine, and ditran: Comparative pharmacology and antagonist in man. Psychophamacologia, 1973;28:131.
9. Vezina P, Blanc G, Glowinski J and Tassin J-P (1992) Nicotine andmorphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: Effects of acute and repeated injections. J Pharmacol Exp Ther 261: 484-490
10. Pidoplichko VI, DeBiasi M, Williams JT and Dani JA (1997) Nicotineactivates and desensitizes midbrain dopamine neurons. Nature (Lond) 390:401-404
11. Nisell M, Nomikos GG and Svensson TH (1994) Systemic nicotine-induceddopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16: 36-44.
12. Barajas-Lopez C, Karanjia R, Espinosa-Luna R. 5-Hydroxytryptamine and atropine inhibit nicotinic receptors in submucosal neurons. Eur J Pharmacol. 2001 Mar 2;414(2-3):113-23.
13. Schilstrom B, Svensson HM, Svensson TH and Nomikos GG (1998) Nicotineand food induced dopamine release in the nucleus accumbens of the rat:Putative role of 7 nicotinic receptors in the ventral tegmental area.Neuroscience 85: 1005-1009.
14. Nisell M, Nomikos GG and Svensson TH (1995) Nicotine dependence,midbrain dopamine systems and psychiatric disorders. Pharmacol Toxicol 76: 157-162.
15. Horger BA and Roth RH (1996) The role of mesoprefrontal dopamine neurons in stress. Crit Rev Neurobiol 10: 395-418.
16. George TP, Verrico CD, Xu L and Roth RH (2000) Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress: Evidence for opioid mechanisms. Neuropsychopharmacology 23: 79-88.
17. Hughes JR, Hatsukami DK, Mitchell JE and Dahlgren LA (1986) Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143: 993-997.
18. Ziedonis DM and George TP (1997) Schizophrenia and nicotine use:Report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull 23: 247-254
19. Yum L, Wolf KM and Chiappinelli VA (1996) Nicotinic acetylcholine receptors in separate brain regions exhibit different affinities for methyllycaconitine. Neuroscience 72: 545-555
20. Bachynsky N. The use of anticholinergic drugs for smoking cessation: a pilot study. Int J Addict. 1986 Jul;21(7):789-805
21. Hill JA, Jr, Zoli M, Bourgeois J-P and Changeaux J-P (1993) Immunocytochemical localization of a neuronal nicotinic receptor: The 2 subunit. J Neurosci 13: 1551-1568
22. Clarke PBS and Pert A (1985) Autoradiographic evidence of nicotine receptors on nigrostriatal and mesolimbic dopamine neurons. Brain Res 348: 355-358